Worldwide Clinical Trials

Worldwide Clinical Trials is a highly specialized, mid-sized global contract research organization (CRO) that provides comprehensive, full-service drug development services to the pharmaceutical and biotechnology industries. Founded by dedicated physicians with a passion for advancing medical science, Worldwide is particularly renowned for its profound expertise in neuroscience (including complex trials for Alzheimer’s disease, Parkinson’s disease, and schizophrenia), cardiovascular diseases, immune-mediated inflammatory disorders, and rare orphan diseases.

With a robust operational footprint spanning over 60 countries globally, Worldwide offers a highly customized, flexible, and hands-on approach to clinical trial management. This approach caters specifically to the unique needs of innovative, emerging biotech firms that often require agile and adaptable study designs, rather than the rigid, template-driven models of larger mega-CROs.

The company prides itself on its rigorous operational methodologies, high-quality biometric data management, and exceptional, proactive site engagement strategies. Worldwide emphasizes a highly accessible executive leadership team and a scientifically collaborative environment that treats sponsor pipelines as their own.

Their Phase I-IV capabilities are supported by advanced technological platforms for rapid data capture, virtual trial management, and risk-based site monitoring. The organization has successfully supported the development of numerous blockbuster drugs and continues to be an invaluable, trusted partner for companies tackling some of the most challenging and urgently needed therapeutic frontiers in modern medicine.